932041-32-2Relevant academic research and scientific papers
Design and synthesis of 3,5-disubstituted benzamide analogues of DNK333 as dual NK1/NK2 receptor probes
Swarna, Venkat Manoj,Undem, Bradley J.,Korlipara, Vijaya L.
, p. 890 - 894 (2007/10/03)
N-[(R,R)-(E)-(3,4-dichlorobenzyl)-3-(2-oxoazepan-3-yl)carbamoyl]allyl-N-methyl-3,5-bis(trifluoromethyl)benzamide (DNK333, 1b) has been reported to be a potent and balanced dual neurokinin (tachykinin) receptor antagonist. A recent clinical trial using DNK
